AbbVie (ABBV) News Today $175.58 +4.06 (+2.37%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period 3 Fantastic Stocks That Could Enjoy a Santa Claus RallyDecember 21 at 6:48 AM | fool.comAbbVie Inc. (NYSE:ABBV) Receives $205.70 Average PT from AnalystsDecember 21 at 2:13 AM | americanbankingnews.comAbbVie (NYSE:ABBV) Shares Down 0.5% After Insider SellingDecember 21 at 1:17 AM | americanbankingnews.comAbbVie (NYSE:ABBV) Shares Up 2% - Time to Buy?AbbVie (NYSE:ABBV) Shares Up 2% - What's Next?December 20 at 2:13 PM | marketbeat.comKevin K Buckbee Executes Sell Order: Offloads $310K In AbbVie StockDecember 20 at 5:51 AM | benzinga.comAbbVie (NYSE:ABBV) Stock Price Down 0.5% on Insider SellingAbbVie (NYSE:ABBV) Stock Price Down 0.5% Following Insider SellingDecember 19 at 11:25 AM | marketbeat.comAbbVie Says Canadian Headache Society Backs Atogepant, OnabotulinumtoxinADecember 19 at 9:40 AM | markets.businessinsider.com2 Top Dividend Stocks to Buy and Hold Through 2025 and BeyondDecember 19 at 6:00 AM | fool.comPiper Sandler Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) StockDecember 19 at 4:27 AM | americanbankingnews.comKevin K. Buckbee Sells 1,800 Shares of AbbVie Inc. (NYSE:ABBV) StockAbbVie Inc. (NYSE:ABBV - Get Free Report) SVP Kevin K. Buckbee sold 1,800 shares of the company's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $172.24, for a total transaction of $310,032.00. Following the completion of the transaction, the senior vice president now owns 6,983 shares of the company's stock, valued at approximately $1,202,751.92. This trade represents a 20.49 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.December 18 at 7:36 PM | marketbeat.comAbbVie’s tavapadon achieves positive topline results in Phase III TEMPO-2 trialDecember 18 at 6:37 PM | finance.yahoo.comAbbVie's (ABBV) Overweight Rating Reaffirmed at Piper Sandler CompaniesDecember 18 at 4:25 AM | americanbankingnews.comAbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of AbbVie Inc. (NYSE:ABBV - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twenty-four brokerages that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendationDecember 18 at 2:39 AM | marketbeat.comAbbVie (NYSE:ABBV) and BriaCell Therapeutics (OTCMKTS:BCTXF) Head to Head ReviewDecember 18 at 2:25 AM | americanbankingnews.comAbbVie's (ABBV) Overweight Rating Reiterated at Piper Sandler CompaniesPiper Sandler Companies restated an "overweight" rating and set a $220.00 target price on shares of AbbVie in a report on Tuesday.December 17, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Price Target Raised to $220.00 at Piper SandlerPiper Sandler lifted their target price on shares of AbbVie from $212.00 to $220.00 and gave the stock an "overweight" rating in a research note on Tuesday.December 17, 2024 | marketbeat.comAbbVie price target raised to $220 from $212 at Piper SandlerDecember 17, 2024 | tipranks.comAbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?December 17, 2024 | investors.com3 High-Potential Dividend Growth Stocks for 2024December 17, 2024 | stocknews.comAbbVie: Pullback Is A Golden Opportunity For Dividend And Growth InvestorsDecember 16, 2024 | seekingalpha.comAbbVie Enters Oversold TerritoryDecember 16, 2024 | forbes.comWant Decades of Passive Income? 3 Stocks to Buy Now and Hold ForeverDecember 15, 2024 | fool.comAbbVie Announces Leadership Change with New AppointmentDecember 14, 2024 | markets.businessinsider.comAbbVie Inc. stock underperforms Friday when compared to competitors despite daily gainsDecember 14, 2024 | marketwatch.comLord Abbett & CO. LLC Decreases Position in AbbVie Inc. (NYSE:ABBV)Lord Abbett & CO. LLC lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 8.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,634,739 shares of the company's stock after selling 1December 14, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by B. Riley Wealth Advisors Inc.B. Riley Wealth Advisors Inc. decreased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 22.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 86,100 shares of the company's stock after selling 24,969 shares during the period. B. Riley Wealth AdvDecember 14, 2024 | marketbeat.comAbbVie Buying Nimble Therapeutics for $200M to Boost Immunology PipelineDecember 13, 2024 | marketwatch.comAbbVie To Acquire Nimble Therapeutics For $200 Mln In CashDecember 13, 2024 | markets.businessinsider.comAbbVie to acquire Nimble Therapeutics for $200M cash at closingDecember 13, 2024 | markets.businessinsider.comAbbVie buying Wisconsin biotech company Nimble Therapeutics for $200 millionDecember 13, 2024 | bizjournals.comAbbVie to buy Madison pharmaceutical tech firm for $200 millionDecember 13, 2024 | bizjournals.comAbbVie (NYSE:ABBV) Stock Price Up 0.1% - Still a Buy?AbbVie (NYSE:ABBV) Trading Up 0.1% - Here's WhyDecember 13, 2024 | marketbeat.comRetirement Systems of Alabama Sells 54,280 Shares of AbbVie Inc. (NYSE:ABBV)Retirement Systems of Alabama cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 901,128 shares of the company's stock after selling 54,280 sharDecember 13, 2024 | marketbeat.com24,146 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Oddo BHF Asset Management SasOddo BHF Asset Management Sas bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 24,146 shares of the company's stDecember 13, 2024 | marketbeat.comAbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology PipelineDecember 13, 2024 | prnewswire.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 13.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,873,744 shares of the company's stock after selling 2,080,7December 13, 2024 | marketbeat.comPeapack Gladstone Financial Corp Purchases 10,697 Shares of AbbVie Inc. (NYSE:ABBV)Peapack Gladstone Financial Corp boosted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 209,463 shares of the company's stock after buyinDecember 13, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Earns "Neutral" Rating from Bank of AmericaDecember 13, 2024 | americanbankingnews.comAbbVie (NYSE:ABBV) Shares Down 0.1% - Should You Sell?AbbVie (NYSE:ABBV) Shares Down 0.1% - What's Next?December 12, 2024 | marketbeat.comWilmington Savings Fund Society FSB Boosts Stock Position in AbbVie Inc. (NYSE:ABBV)Wilmington Savings Fund Society FSB grew its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 157.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 82,223 shares of the company's stock after buying an additional 50,231 shares during the period. WilmingtDecember 12, 2024 | marketbeat.comArvest Bank Trust Division Takes Position in AbbVie Inc. (NYSE:ABBV)Arvest Bank Trust Division bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 91,224 shares of the company's stock, valued at approximately $18,015,000. Several other institutionDecember 12, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by World Investment Advisors LLCWorld Investment Advisors LLC trimmed its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 7.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 48,390 shares of the company's stock after sellingDecember 12, 2024 | marketbeat.comSanctuary Advisors LLC Has $104.43 Million Stake in AbbVie Inc. (NYSE:ABBV)Sanctuary Advisors LLC grew its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 23.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 528,802 shares of the company's stock after acquiring an additional 101,455 shareDecember 12, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Bought by Pine Valley Investments Ltd Liability CoPine Valley Investments Ltd Liability Co raised its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 12.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,787 shares of the company's stock afterDecember 12, 2024 | marketbeat.comWealthquest Corp Has $545,000 Stock Holdings in AbbVie Inc. (NYSE:ABBV)Wealthquest Corp lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 55.8% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,766 shares of the company's stock after selling 3,495 shares during the period. WealthqueDecember 12, 2024 | marketbeat.com1 Magnificent S&P 500 Dividend Stock Down 14% to Buy and Hold ForeverDecember 12, 2024 | fool.comAnalyst Scoreboard: 19 Ratings For AbbVieDecember 11, 2024 | benzinga.comAbbVie (NYSE:ABBV) Shares Down 0.1% - Here's What HappenedAbbVie (NYSE:ABBV) Stock Price Down 0.1% - What's Next?December 11, 2024 | marketbeat.comBetting Big On AbbVie: A Prescription For Growth And DividendsDecember 11, 2024 | seekingalpha.comBetting Big On AbbVie: A Prescription For Growth And DividendsDecember 11, 2024 | seekingalpha.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.540.60▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼2831▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today JAZZ News Today CORT News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABBV Stock Alerts